PATENT CLAIM ANALYSIS

Application Number: 15883495
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "365000"]

Abstract:
The present disclosure relates to novel compounds, pharmaceutical compositions containing such compounds, and their use in prevention and treatment of estrogen-related diseases and conditions.

Claim (Index 37):
The method according to  claim 36 , wherein the anti-cancer agent is tamoxifen.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 86.0
- Lexical Diversity: 1.17391
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15646793', '14822309', '15374966', '14898832', '15881318']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6978432780402753
- 35 USC 102 Novelty (BERT): 0.5606797714416677
- Combined Prediction Score: 0.6841269273804146
- Mean Citation Score: 299.484412
- Max Citation Score: 455.72318
- Similarity Product: 271.9904654469609

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test